Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma

被引:7
作者
Agirre-Lizaso, Alona [1 ]
Huici-Izagirre, Maider [1 ]
Urretabizkaia-Garmendia, Josu [1 ]
Rodrigues, Pedro M. [1 ,2 ,3 ]
Banales, Jesus M. [1 ,2 ,3 ,4 ]
Perugorria, Maria J. [1 ,2 ,5 ]
机构
[1] Univ Basque Country, Donostia Univ Hosp, Biodonostia Res Inst, Dept Liver & Gastrointestinal Dis,UPV EHU, Donostia San Sebastian 20014, Spain
[2] Inst Salud Carlos III ISCIII, Ctr Study Liver & Gastrointestinal Dis CIBERehd, Madrid 28029, Spain
[3] Basque Fdn Sci, IKERBASQUE, Bilbao 48009, Spain
[4] Univ Navarra, Sch Sci, Dept Biochem & Genet, Pamplona 31008, Spain
[5] Univ Basque Country, Fac Med & Nursing, Dept Med, UPV EHU, Donostia San Sebastian 20014, Spain
关键词
liver cancer; hepatocellular carcinoma; immunotherapy; tumour microenvironment; tumour-associated macrophages; innate immune system; macrophage reprogramming; EPITHELIAL-MESENCHYMAL TRANSITION; LIVER MACROPHAGES; DOUBLE-BLIND; C/EBP-ALPHA; CELLS; SORAFENIB; PROMOTE; GROWTH; MICROENVIRONMENT; POLARIZATION;
D O I
10.3390/cancers15204977
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Hepatocellular carcinoma (HCC) is a highly lethal disease with an increasing incidence. Despite the advancements in diagnosis and recent therapeutic options, improving the prognosis of HCC patients remains challenging. One of the reasons of the unsatisfactory outcome of patients with HCC is the complex tumour microenvironment (TME), which is composed of immune and stromal cells, limiting effective treatments. Recent research has highlighted the importance of macrophages in the development and progression of HCC, opening new possibilities for therapy. This review focuses on the heterogeneity of tumour-associated macrophages (TAMs) in HCC, the mechanisms through which HCC tumour cells polarize macrophages, and the therapeutic targets that are currently being tested to explore novel therapies that can improve the prognosis and quality of life of HCC patients.Abstract Hepatocellular carcinoma (HCC) is a prevalent and aggressive cancer that comprises a complex tumour microenvironment (TME). Tumour-associated macrophages (TAMs) are one of the most abundant immune cells present in the TME, and play a key role both in the development and in the progression of HCC. Thus, TAM-based immunotherapy has been presented as a promising strategy to complement the currently available therapies for HCC treatment. Among the novel approaches focusing on TAMs, reprogramming their functional state has emerged as a promising option for targeting TAMs as an immunotherapy in combination with the currently available treatment options. Nevertheless, a further understanding of the immunobiology of TAMs is still required. This review synthesizes current insights into the heterogeneous nature of TAMs in HCC and describes the mechanisms behind their pro-tumoural polarization focusing the attention on their interaction with HCC cells. Furthermore, this review underscores the potential involvement of TAMs' reprogramming in HCC therapy and highlights the urgency of advancing our understanding of these cells within the dynamic landscape of HCC.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] α-Fetoprotein and other tumour-associated antigens for immunotherapy of hepatocellular cancer
    Evdokimova, Viktoria N.
    Butterfield, Lisa H.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (03) : 325 - 336
  • [32] Targeted depletion of tumour-associated macrophages by an alendronate-glucomannan conjugate for cancer immunotherapy
    Zhan, Xiudan
    Jia, Lixin
    Niu, Yiming
    Qi, Haixia
    Chen, Xiuping
    Zhang, Qingwen
    Zhang, Junfeng
    Wang, Yitao
    Dong, Lei
    Wang, Chunming
    [J]. BIOMATERIALS, 2014, 35 (38) : 10046 - 10057
  • [33] Tumour-associated macrophages might represent a favourable prognostic indicator in patients with papillary renal cell carcinoma
    Hutterer, Georg C.
    Pichler, Martin
    Chromecki, Thomas F.
    Strini, Karin A.
    Klatte, Tobias
    Pummer, Karl
    Remzi, Mesut
    Mannweiler, Sebastian
    Zigeuner, Richard
    [J]. HISTOPATHOLOGY, 2013, 63 (03) : 309 - 315
  • [34] The Role of Tumor Associated Macrophages in Hepatocellular Carcinoma
    Huang, Yu
    Ge, Wenhao
    Zhou, Jiarong
    Gao, Bingqiang
    Qian, Xiaohui
    Wang, Weilin
    [J]. JOURNAL OF CANCER, 2021, 12 (05): : 1284 - 1294
  • [35] The Heterogeneity of Tumour-Associated Macrophages Contributes to the Recurrence and Outcomes of Glioblastoma Patients
    Zixue Xuan
    Ling Fang
    Guobing Zhang
    Xin Zhang
    Jinying Jiang
    Kai Wang
    Ping Huang
    [J]. Journal of Molecular Neuroscience, 2023, 73 : 1 - 14
  • [36] The Heterogeneity of Tumour-Associated Macrophages Contributes to the Recurrence and Outcomes of Glioblastoma Patients
    Xuan, Zixue
    Fang, Ling
    Zhang, Guobing
    Zhang, Xin
    Jiang, Jinying
    Wang, Kai
    Huang, Ping
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 2023, 73 (01) : 1 - 14
  • [37] Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment
    Zheng, Xiang
    Mansouri, Siavash
    Krager, Annika
    Grimminger, Friedrich
    Seeger, Werner
    Pullamsetti, Soni S.
    Wheelock, Craig E.
    Savai, Rajkumar
    [J]. EUROPEAN RESPIRATORY REVIEW, 2020, 29 (157) : 1 - 14
  • [38] Research progress on tumour-associated macrophages in gastric cancer
    Zhou, Zidi
    Yang, Zhilong
    Wang, Jingzhi
    Wang, Qiang
    Zhang, Heng
    Ju, Xiaoli
    [J]. ONCOLOGY REPORTS, 2021, 45 (04)
  • [39] The role of osteoclasts and tumour-associated macrophages in osteosarcoma metastasis
    Endo-Munoz, Liliana
    Evdokiou, Andreas
    Saunders, Nicholas A.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2012, 1826 (02): : 434 - 442
  • [40] CD206 accelerates hepatocellular carcinoma progression by regulating the tumour immune microenvironment and increasing M2-type polarisation of tumour-associated macrophages and inflammation factor expression
    Mao, Zhiyuan
    Han, Yalin
    Li, Yinglin
    Bai, Li
    [J]. DISCOVER ONCOLOGY, 2024, 15 (01)